Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,971 | -2,643 | -69,429 | -36,732 | -25,989 |
| Depreciation Amortization | 780 | 385 | 3,896 | 2,307 | 1,511 |
| Accounts receivable | 1,669 | 2,117 | -2,175 | -690 | -885 |
| Other Working Capital | -7,156 | -5,271 | 73,121 | -2,372 | -2,940 |
| Other Operating Activity | 16,410 | 228 | 5,989 | 4,078 | 3,248 |
| Operating Cash Flow | $-5,268 | $-5,184 | $11,402 | $-33,409 | $-25,055 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -31,240 | -35,160 | -80,365 | -61,081 | -16,313 |
| PPE Investments | -3,005 | -822 | -1,212 | -761 | -391 |
| Net Acquisitions | -13,128 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -3 | -1 | -3 | -1 | 0 |
| Investing Cash Flow | $-47,376 | $-35,983 | $-81,580 | $-61,843 | $-16,704 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,859 | 2,446 | 136,791 | 135,863 | 65,047 |
| Other Financing Activity | 0 | 0 | -4,768 | -4,767 | -2,173 |
| Financing Cash Flow | $3,859 | $2,446 | $132,023 | $131,096 | $62,874 |
| Beginning Cash Position | 67,072 | 67,072 | 5,227 | 5,227 | 5,227 |
| End Cash Position | 18,287 | 28,351 | 67,072 | 41,071 | 26,342 |
| Net Cash Flow | $-48,785 | $-38,721 | $61,845 | $35,844 | $21,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,268 | -5,184 | 11,402 | -33,409 | -25,055 |
| Capital Expenditure | -3,005 | -822 | -1,212 | -761 | -391 |
| Free Cash Flow | -8,273 | -6,006 | 10,190 | -34,170 | -25,446 |